Literature DB >> 10920072

Favorable remodeling enhances recovery of regional myocardial function in the weeks after infarction in ischemically preconditioned hearts.

M V Cohen1, X M Yang, T Neumann, G Heusch, J M Downey.   

Abstract

BACKGROUND: In a previous study, we found that recovery of segment shortening in the ischemic zone of conscious, chronically instrumented rabbits was significantly better in ischemically preconditioned than control animals after 72 hours of reperfusion. However, although this period of reperfusion was felt to be sufficient to allow recovery from stunning, regional function was disproportionately low for the size of the infarcts. METHODS AND
RESULTS: To further characterize the recovery of left ventricular regional function, rabbits were chronically instrumented with a balloon occluder around a branch of the left coronary artery and a pair of ultrasonic crystals to monitor segment shortening in the ischemic zone. The preconditioned group had 1 cycle of 5-minute occlusion/10-minute reperfusion before a 30-minute occlusion, whereas control rabbits experienced only the 30-minute occlusion. All monitored segments were either dyskinetic or akinetic during the 30-minute occlusion. There was no difference in function between the 2 groups until 24 hours of reperfusion. At 72 hours, systolic shortening in control hearts averaged only 5% of the preischemic value, whereas shortening was 29% of baseline in preconditioned hearts. By day 21, systolic shortening averaged 26% in control hearts and 65% in preconditioned hearts (P<0.02) and appeared to have reached a plateau. Infarct size was 31.4+/-2.8% and 15.5+/-2.1% in control and preconditioned hearts, respectively. Moreover, in ischemically preconditioned hearts, the recovery of regional function was better than in controls for any given amount of microinfarction in the myocardial segment between crystals (P=0.02).
CONCLUSIONS: The progressive improvement in preconditioned hearts is most consistent with favorable remodeling in the ischemic zone, which the preconditioning process seems to accentuate.

Entities:  

Mesh:

Year:  2000        PMID: 10920072     DOI: 10.1161/01.cir.102.5.579

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 2.  Continuous internal counterpulsation as a bridge to recovery in acute and chronic heart failure.

Authors:  Christos D Kontogiannis; Konstantinos Malliaras; Chris J Kapelios; Jay W Mason; John N Nanas
Journal:  World J Transplant       Date:  2016-03-24

3.  The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study.

Authors:  Alberto Palazzuoli; Matteo Beltrami; Luigi Gennari; A Ghosh Dastidar; Ranuccio Nuti; Elisa McAlindon; Gianni D Angelini; Chiara Bucciarelli-Ducci
Journal:  Int J Cardiovasc Imaging       Date:  2015-04-12       Impact factor: 2.357

4.  Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice.

Authors:  Virginia Perez; Verónica D Annunzio; Tamara Mazo; Timoteo Marchini; Lourdes Caceres; Pablo Evelson; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2016-03-01       Impact factor: 3.396

5.  Impact of microvascular integrity and local viability on left ventricular remodelling after reperfused acute myocardial infarction.

Authors:  P Garot; O Pascal; M Simon; J L Monin; E Teiger; J Garot; P Guéret; J L Dubois-Randé
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

6.  Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Authors:  Bruno Buchholz; Martín Donato; Verónica D'Annunzio; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2014-03-13       Impact factor: 3.396

Review 7.  A Glimpse Into the Future of Transcatheter Interventional Heart Failure Therapies.

Authors:  Roberto C Cerrud-Rodriguez; Daniel Burkhoff; Azeem Latib; Juan F Granada
Journal:  JACC Basic Transl Sci       Date:  2021-11-24

8.  Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1.

Authors:  Verónica D Annunzio; Virginia Perez; Tamara Mazo; Marina C Muñoz; Fernando P Dominici; María C Carreras; Juan José Poderoso; Junichi Sadoshima; Ricardo J Gelpi
Journal:  Oncotarget       Date:  2016-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.